News
This certification is a recognition of the excellence standards achieved by Bioiberica in their effort to improve energy efficiencyDuring the next three years, our company has set the following objectives: 15% reduction in energy consumption per production unit, 10% of the energy will come from by-product use, and 5% from renewable energies
Bioiberica has been assigned to the A group, which corresponds to companies having their own R&D center and production plant, with a significant volume of research.The biotech company invests close to13% of its profits into R&D, and during 2013 they intend to begin marketing their personalized medicine range of products for osteoarthritis treatment.
On March 15th, Bioiberica held at the Colegio Oficial de Veterinarios of Seville, Spain, a scientific session on interesting future trends in immunology and immunomodulation
Bioiberica is rated good and remains within the A group, representing companies with significant research activity The Spanish chemical-pharmaceutical company, which employs 386 workers, has more than 58 R&D projects currently under development.
Condrovet Taste evolves: now it is sold in boxes of 40, 80, 120 or 140 capsules. This new package design replaces the old boxes of 60, 100, 140 or 240 capsules.